TriSalus Life Sciences appoints Michael Stansky to board, replacing Dr. Desai

TriSalus Life Sciences, Inc.

Dr. Arjun "JJ" Desai resigned from the board on February 3, 2026; no disagreement with the company.
Michael P. Stansky appointed to the board effective February 4, 2026.
Stansky brings 40 years of investment management and healthcare experience; former Managing Director at Tudor Investment Corp.
He will serve on the Audit, Compensation, and Science and Technology Committees.
Stansky currently serves on boards of Insightec and Momentis Surgical; past boards include Mako Surgical and Transmedics.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.